TMO · 10-Q · 2026Q3 · Full report

Operating Cash Flow Trends

THERMO FISHER SCIENTIFIC INC. · 2026-10-30 · Importance 52 · Surprise 56 · From source text

Net cash provided by operating activities increased to $5.867 billion in the first nine months of 2026 from $4.361 billion in the comparable 2025 period. Free cash flow rose to $4.618 billion from $3.319 billion, while net cash used in investing activities increased to $8.874 billion from $4.938 billion. First-nine-month 2026 working-capital uses included $0.54 billion from higher accounts receivable and $0.43 billion from lower accounts payable. Cash income-tax payments were $0.94 billion in the 2026 period, compared with $1.60 billion a year earlier.

Key facts

• Thermo Fisher Scientific Inc.’s net cash provided by operating activities was $5.867 billion in the first nine months of 2026, compared with $4.361 billion in the first nine months of 2025. source
• Thermo Fisher Scientific Inc.’s free cash flow was $4.618 billion in the first nine months of 2026, compared with $3.319 billion in the first nine months of 2025. source
• Thermo Fisher Scientific Inc.’s cash payments for income taxes were $1.60 billion during the first nine months of 2025. source
• Thermo Fisher Scientific Inc.’s cash payments for income taxes were $0.94 billion during the first nine months of 2026. source
• In the first nine months of 2025, changes in Thermo Fisher Scientific Inc.’s other assets and liabilities used $1.21 billion of cash, primarily due to the timing of compensation and income tax payments. source
• In the first nine months of 2026, an increase in Thermo Fisher Scientific Inc.’s accounts receivable used $0.54 billion of cash and a decrease in accounts payable used $0.43 billion of cash. source

Impact estimates